Mostufi-Zadeh-Haghighi, G.; Veratti, P.; Zodel, K.; Greve, G.; Waterhouse, M.; Zeiser, R.; Cleary, M.L.; Lübbert, M.; Duque-Afonso, J.
Functional Characterization of Transforming Growth Factor-β Signaling in Dasatinib Resistance and Pre-BCR+ Acute Lymphoblastic Leukemia. Cancers 2023, 15, 4328.
https://doi.org/10.3390/cancers15174328
AMA Style
Mostufi-Zadeh-Haghighi G, Veratti P, Zodel K, Greve G, Waterhouse M, Zeiser R, Cleary ML, Lübbert M, Duque-Afonso J.
Functional Characterization of Transforming Growth Factor-β Signaling in Dasatinib Resistance and Pre-BCR+ Acute Lymphoblastic Leukemia. Cancers. 2023; 15(17):4328.
https://doi.org/10.3390/cancers15174328
Chicago/Turabian Style
Mostufi-Zadeh-Haghighi, Gila, Pia Veratti, Kyra Zodel, Gabriele Greve, Miguel Waterhouse, Robert Zeiser, Michael L. Cleary, Michael Lübbert, and Jesús Duque-Afonso.
2023. "Functional Characterization of Transforming Growth Factor-β Signaling in Dasatinib Resistance and Pre-BCR+ Acute Lymphoblastic Leukemia" Cancers 15, no. 17: 4328.
https://doi.org/10.3390/cancers15174328
APA Style
Mostufi-Zadeh-Haghighi, G., Veratti, P., Zodel, K., Greve, G., Waterhouse, M., Zeiser, R., Cleary, M. L., Lübbert, M., & Duque-Afonso, J.
(2023). Functional Characterization of Transforming Growth Factor-β Signaling in Dasatinib Resistance and Pre-BCR+ Acute Lymphoblastic Leukemia. Cancers, 15(17), 4328.
https://doi.org/10.3390/cancers15174328
